Literature DB >> 8206977

Phosphorylation of the erythroid transcription factor GATA-1.

M Crossley1, S H Orkin.   

Abstract

GATA-1 is a zinc finger DNA-binding protein thought to be involved in the expression of the vast majority of erythroid specific genes. We have examined the phosphorylation of GATA-1 in murine erythroleukemia (MEL) cells and have mapped the sites of phosphorylation by overexpression of GATA-1 in monkey kidney COS cells. We show that GATA-1 is phosphorylated on 6 serines within its amino terminus in uninduced MEL cells and that a 7th site, serine 310, becomes phosphorylated after MEL cells are induced to differentiate by exposure to dimethyl sulfoxide. This site lies near the carboxyl boundary of the DNA-binding domain in a conserved region of the protein believed to be involved in DNA bending. Detailed analyses indicate, however, that phosphorylation at this site, or the other sites identified, does not significantly influence DNA-binding affinity or specificity, DNA bending, or transcriptional transactivation by GATA-1.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8206977

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  41 in total

1.  Potentiation of GATA-2 activity through interactions with the promyelocytic leukemia protein (PML) and the t(15;17)-generated PML-retinoic acid receptor alpha oncoprotein.

Authors:  S Tsuzuki; M Towatari; H Saito; T Enver
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

2.  Modification of the erythroid transcription factor GATA-1 by SUMO-1.

Authors:  Licio Collavin; Monica Gostissa; Fabio Avolio; Paola Secco; Antonella Ronchi; Claudio Santoro; Giannino Del Sal
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-01       Impact factor: 11.205

3.  GATA1 function, a paradigm for transcription factors in hematopoiesis.

Authors:  Rita Ferreira; Kinuko Ohneda; Masayuki Yamamoto; Sjaak Philipsen
Journal:  Mol Cell Biol       Date:  2005-02       Impact factor: 4.272

4.  PDSM, a motif for phosphorylation-dependent SUMO modification.

Authors:  Ville Hietakangas; Julius Anckar; Henri A Blomster; Mitsuaki Fujimoto; Jorma J Palvimo; Akira Nakai; Lea Sistonen
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-21       Impact factor: 11.205

5.  Phosphorylation of Gata1 at serine residues 72, 142, and 310 is not essential for hematopoiesis in vivo.

Authors:  Heather M Rooke; Stuart H Orkin
Journal:  Blood       Date:  2006-01-03       Impact factor: 22.113

6.  MAPK-mediated phosphorylation of GATA-1 promotes Bcl-XL expression and cell survival.

Authors:  Yung-Luen Yu; Yun-Jung Chiang; Yu-Chun Chen; Michael Papetti; Chiun-Gung Juo; Arthur I Skoultchi; Jeffrey J Y Yen
Journal:  J Biol Chem       Date:  2005-06-20       Impact factor: 5.157

7.  Silencing of Agamma-globin gene expression during adult definitive erythropoiesis mediated by GATA-1-FOG-1-Mi2 complex binding at the -566 GATA site.

Authors:  Susanna Harju-Baker; Flávia C Costa; Halyna Fedosyuk; Renee Neades; Kenneth R Peterson
Journal:  Mol Cell Biol       Date:  2008-03-17       Impact factor: 4.272

Review 8.  Role of the GATA family of transcription factors in endocrine development, function, and disease.

Authors:  Robert S Viger; Séverine Mazaud Guittot; Mikko Anttonen; David B Wilson; Markku Heikinheimo
Journal:  Mol Endocrinol       Date:  2008-01-03

9.  GATA transcription factors in vertebrates: evolutionary, structural and functional interplay.

Authors:  Yanyan Tang; Yunfei Wei; Wenwu He; Yongbo Wang; Jianing Zhong; Chao Qin
Journal:  Mol Genet Genomics       Date:  2013-12-25       Impact factor: 3.291

10.  Phosphatidylinositol 3-kinase/Akt induced by erythropoietin renders the erythroid differentiation factor GATA-1 competent for TIMP-1 gene transactivation.

Authors:  Zahra Kadri; Leila Maouche-Chretien; Heather M Rooke; Stuart H Orkin; Paul-Henri Romeo; Patrick Mayeux; Philippe Leboulch; Stany Chretien
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.